Best EDC systems for clinical trials in 2026

Compare features

Compare clinical-trial data collection by the workflow required: participant forms and follow-up, or site-entered eCRFs, clinical queries and database management. WeGuide is included for participant-data collection and ongoing engagement, with connections to a dedicated EDC when additional clinical-data workflows are needed. Each feature links to its public source.

Best forResearch teams, sponsors and CROs comparing data collection for clinical trials, from focused participant-centered studies to complex multi-site protocols.

Updated Nov 13, 20269 tools compared

What is an EDC system?

EDC stands for electronic data capture. These systems hold the structured clinical data collected in a study, often through electronic case report forms completed by research sites. They help data teams check entries, resolve questions and prepare the dataset for analysis.

Background: Castor electronic data capture overview

What this software typically does

  • Build electronic case report forms
  • Validate entries and manage data queries
  • Maintain audit trails and export study datasets
Compare features

Compare product features

See documented feature support at a glance. Select a symbol for the explanation and source. Double checks indicate documented extra capabilities; unknown does not mean unavailable.

Products are not ranked. Table order is chosen for each guide and does not indicate a recommendation.

Select a symbol to read its evidence and source. Scroll sideways for all features.

Documented feature support for each product. Symbols describe individual features, not overall product ratings.
SoftwareTrack record in regulated multi-site trialsStudy build and mid-study changesCompliance and securityPlatform breadthAPIs and data standardsPublished pricing and terms
Medidata Rave EDC

Supported

Supported means: Published product or wider-platform adoption, or a named clinical-research deployment.

Medidata's Rave EDC page reports 38K+ studies, 1.8M+ users and 25+ years in use.

Source

Extended support

Drag-and-drop study build and mid-study changes with no downtime are both stated.

Extended support means: Study setup is described, and post-go-live changes explicitly avoid interrupting live study use.

Medidata states that Rave deploys mid-study changes with no downtime and that studies are built with drag-and-drop design and libraries of pre-validated eCRFs.

Source

Supported

Trial position statements are customer-only; listed ISO/SOC claims do not establish public document access.

Supported means: Relevant trial compliance or security controls are stated, with their scope identified.

Medidata lists ISO 27001:2022, ISO 27017, ISO 27018, ISO 27701 and a SOC 2+ Type II audit, and provides 21 CFR Part 11 position statements to customers.

Source

Extended support

Native RTSM, medical coding, eCOA and eConsent are named alongside EDC.

Extended support means: Native randomization, trial supply management, medical coding, and either eCOA or ePRO are documented alongside EDC.

Rave EDC connects to Medidata's own RTSM, Coder+, eCOA, eConsent, Imaging and Clinical Data Studio.

Source

Extended support

Rave Web Services exchanges clinical data through REST in CDISC ODM.

Extended support means: An API plus data exchange in a named CDISC format are documented.

Rave Web Services is a REST API that exchanges data in CDISC ODM, and Medidata lists Health Record Connect for EHR data on its EDC page.

Source

Unknown

Calling Rave Lite pricing flexible does not describe a pricing basis or contract terms.

The available evidence does not establish this feature. This does not mean it is unavailable.

Medidata publishes no prices; its EDC page only says Rave Lite has a flexible pricing model.

Source
Castor

Extended support

The vendor reports EDC study and participant figures across a stated country count.

Extended support means: Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.

Castor reports more than 31,900 studies with 9.5 million participants in 171 countries, but its pages give no evidence of global Phase III programs.

Source

Supported

Self-build and audited mid-study edits are stated; uninterrupted live use is not claimed.

Supported means: Study setup or post-go-live study changes are described.

Castor offers self-service build with a low-code eCRF builder and reusable templates, and says forms can be edited mid-study with audit trails and separate test environments, without a no-downtime claim.

Source

Supported

Trial standards and ISO certification are listed; public certificate or report access is not established.

Supported means: Relevant trial compliance or security controls are stated, with their scope identified.

Castor lists FDA 21 CFR Part 11, EU Annex 11 and ISO 27001 among its compliance standards.

Source

Supported

eConsent, ePRO/eCOA and eSource establish connected modules; native supply and coding are not listed.

Supported means: EDC connects to another named clinical-trial module.

Castor's EDC page lists eConsent, ePRO/eCOA and eSource; it lists no native trial supply management, coding or CTMS.

Source

Supported

An API and FHIR alignment are stated; named CDISC-format exchange is not established.

Supported means: An API for clinical data exchange is stated.

Castor offers an open API, says it aligns with HL7 FHIR and integrates with EHRs, but makes no specific CDISC export claim.

Source

Supported

Supported means: A pricing basis, model or contract terms are published beyond contact sales.

No prices published; Castor's pricing page describes an itemized, fixed-scope proposal with change-control terms, sent within five business days.

Source
Medrio

Supported

International use is stated, but study, customer, site or participant adoption figures are not given.

Supported means: Published product or wider-platform adoption, or a named clinical-research deployment.

Medrio cites 20+ years of use, sites in 30+ countries and trials from early feasibility to pivotal studies, but its current pages show no study count.

Source

Supported

Updates avoid extended downtime; the note does not establish uninterrupted live use.

Supported means: Study setup or post-go-live study changes are described.

Medrio describes a no-code drag-and-drop builder with a template library and says updates deploy without data migration, vendor delays or extended downtime.

Source

Supported

Trial standards and a completed SOC examination are stated; public report access is not established.

Supported means: Relevant trial compliance or security controls are stated, with their scope identified.

Medrio completed a SOC 2 Type 2 examination in 2022, and its EDC page states support for 21 CFR Part 11, ICH E6(R2), HIPAA and GDPR.

Source

Supported

Connected clinical modules are listed; medical coding is not documented.

Supported means: EDC connects to another named clinical-trial module.

Medrio lists EDC, ePRO/eCOA, eConsent, RTSM (randomization and supply), CTMS and eTMF; coding is not listed.

Source

Supported

Import/export APIs establish base support; no named CDISC format is given.

Supported means: An API for clinical data exchange is stated.

Medrio mentions import and export APIs and industry-standard exports but publishes no API documentation or named CDISC format.

Source

Supported

Supported means: A pricing basis, model or contract terms are published beyond contact sales.

No prices published; Medrio describes its pricing as subscription-based.

Source
OpenClinica

Supported

Supported means: Published product or wider-platform adoption, or a named clinical-research deployment.

OpenClinica says its technology has powered over 15,000 studies and more than three million patients.

Source

Supported

Self-build and managed build are stated; amendment deployment is not documented.

Supported means: Study setup or post-go-live study changes are described.

OpenClinica offers drag-and-drop self-build with CDASH templates or a free expert-managed build, but does not publicly document how amendments deploy.

Source

Supported

Trial standards and ISO/SOC claims are stated; public certificate or report access is not established.

Supported means: Relevant trial compliance or security controls are stated, with their scope identified.

OpenClinica states 21 CFR Part 11, ICH GCP, HIPAA and GDPR compliance and lists SOC 2 Type II and ISO 27001 certification.

Source

Supported

eConsent, eCOA and randomization establish base support despite the stated absence of native supply and coding.

Supported means: EDC connects to another named clinical-trial module.

OpenClinica lists EDC with eConsent, eCOA, randomization, EHR-to-EDC and reporting; it has no native trial supply management or coding.

Source

Extended support

The REST API imports and retrieves clinical data in CDISC ODM.

Extended support means: An API plus data exchange in a named CDISC format are documented.

OpenClinica documents a REST API that imports and retrieves clinical data as CDISC ODM 1.3.2 XML or JSON, and it offers EHR-to-EDC.

Source

Extended support

Monthly production prices and the per-study contract term are published.

Extended support means: Production prices or a free production option are published, with amounts and conditions stated.

OpenClinica publishes prices: EDC-only Launch at $750 a month with a 30-day free trial, and Core at $3,000 a month per study on a 12-month contract.

Source
Oracle

Unknown

An analyst assessment does not establish product adoption or a named trial deployment.

The available evidence does not establish this feature. This does not mean it is unavailable.

Everest Group rated Oracle a Leader in its 2024 EDC assessment, but we found no published Clinical One study or customer count.

Source

Supported

Live-study versioning is documented; uninterrupted changes are not established.

Supported means: Study setup or post-go-live study changes are described.

Oracle documents versioned changes to live studies, including Advanced Study Versioning and several versions in production, but we could not load an Oracle page that states changes run without downtime.

Source

Supported

Electronic signatures and audit trails establish base controls; a Clinical One Part 11 statement was not found.

Supported means: Relevant trial compliance or security controls are stated, with their scope identified.

Oracle documents electronic signatures and audit-trail datasets for Clinical One, and its cloud compliance page lists ISO 27001 attestations by line of business, but we found no public Part 11 statement specific to Clinical One.

Source

Supported

Native randomization, supply and coding are documented; eCOA and eConsent use partners.

Supported means: EDC connects to another named clinical-trial module.

Clinical One combines data collection with randomization and trial supply management, Central Coding and Analytics; eCOA and eConsent come through partner integrations.

Source

Extended support

REST APIs, ODM-format integrations and CDISC LAB intake are documented.

Extended support means: An API plus data exchange in a named CDISC format are documented.

Oracle documents about 18 REST APIs for Clinical One, ODM-format integrations, CDISC LAB data intake and a catalog of named integrations.

Source

Unknown

The note finds neither published prices nor a pricing model.

The available evidence does not establish this feature. This does not mean it is unavailable.

Oracle publishes no Clinical One prices or pricing model.

Source
WeGuide

Supported

Named research deployments establish base support; the evidence does not establish full EDC deployment counts.

Supported means: Published product or wider-platform adoption, or a named clinical-research deployment.

Public research examples include BRACE and INHERIT. These document research use of the participant platform, rather than counts of full enterprise EDC deployments or regulatory submissions.

Source

Supported

Study configuration is documented; a no-interruption EDC amendment workflow is not.

Supported means: Study setup or post-go-live study changes are described.

Study teams configure forms, question types, conditional logic, input validation and testing. This supports focused trial data collection; uninterrupted enterprise-EDC database amendments are not established by the public material.

Source

Supported

Public statements establish the documented-support level; no public certificate or audit report establishes extended support.

Supported means: Relevant trial compliance or security controls are stated, with their scope identified.

WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report.

Source

Supported

Connected participant modules and external EDC exchange are documented; the full native-suite definition is not met.

Supported means: EDC connects to another named clinical-trial module.

Study programs combine participant forms, ePRO, consent and follow-up. REDCap and other EDC connections can be configured where additional clinical-data workflows require them. A native enterprise EDC, medical-coding and supply-management suite is not claimed.

Source

Supported

An API establishes support; named CDISC exchange has not been established.

Supported means: An API for clinical data exchange is stated.

REST and FHIR integration methods are documented. A named CDISC-format export is not established in the reviewed public material.

Source

Supported

Supported means: A pricing basis, model or contract terms are published beyond contact sales.

WeGuide publishes a per-study quote basis. Contact the team for a study-specific quote; numerical prices are not published.

Source
REDCap

Extended support

The consortium reports institution and project adoption across a stated country count.

Extended support means: Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.

The REDCap Consortium lists 8,526 institutions in 167 countries and 2.9M projects, but REDCap is licensed to non-profits and its use is concentrated in academic research.

Source

Supported

Self-build and approval of production changes are stated; uninterrupted changes are not established.

Supported means: Study setup or post-go-live study changes are described.

Teams build REDCap projects themselves in the online designer, and changes to live projects are drafted and approved in production mode.

Source

Supported

Part 11 support depends on institutional setup; the note also identifies a non-compliant host.

Supported means: Relevant trial compliance or security controls are stated, with their scope identified.

Vanderbilt says REDCap can be installed for 21 CFR Part 11 compliance, but this depends on each institution's setup; Penn Medicine, for example, states its REDCap is not Part 11-compliant.

Source

Supported

Randomization, eConsent and surveys establish base support despite the stated absence of supply, coding and CTMS.

Supported means: EDC connects to another named clinical-trial module.

REDCap includes randomization, e-Consent and participant surveys, but no trial supply management, coding or CTMS.

Source

Extended support

An API and CDISC ODM export are documented.

Extended support means: An API plus data exchange in a named CDISC format are documented.

REDCap has an API and exports CDISC ODM (per Yale's REDCap guide), and the REDCap software page documents EHR data pulls over FHIR.

Source

Extended support

Production use is free for eligible nonprofit consortium members; for-profit organizations are excluded.

Extended support means: Production prices or a free production option are published, with amounts and conditions stated.

REDCap is free for non-profit members of the REDCap Consortium; for-profit organizations are not eligible.

Source
Veeva

Supported

Supported means: Published product or wider-platform adoption, or a named clinical-research deployment.

Veeva reports 100+ EDC customers and says eight of the top 20 biopharmas have switched to Veeva EDC, but publishes no study count.

Source

Supported

Amendments avoid system shutdown, but deployment includes a brief casebook lockout.

Supported means: Study setup or post-go-live study changes are described.

Veeva's white paper states that amendments add new elements without bringing the system down or migrating data, with only a brief casebook lockout while a change deploys.

Source

Supported

Part 11 eSignature and ISO/SOC statements are given; public certificate or report access is not established.

Supported means: Relevant trial compliance or security controls are stated, with their scope identified.

Veeva's trust page lists ISO 27001, ISO 27017, ISO 27018 and a SOC 2 Type II report, and its EDC help docs state that Veeva EDC eSignature meets 21 CFR Part 11.

Source

Supported

Connected clinical applications are listed; native medical coding is not established in this note.

Supported means: EDC connects to another named clinical-trial module.

Veeva's clinical data suite lists EDC, eCOA, RTSM (randomization and supply) and DQS data management, and Veeva also sells CTMS and eConsent.

Source

Supported

The API uses an ODM-like model; the only stated ODM export is legacy.

Supported means: An API for clinical data exchange is stated.

Veeva documents a versioned CDMS API for study data, definitions and coding requests with a data model similar to CDISC ODM, but its ODM casebook export is a legacy feature.

Source

Unknown

The note finds neither published prices nor a pricing model.

The available evidence does not establish this feature. This does not mean it is unavailable.

Veeva publishes no EDC prices or pricing model.

Source
Viedoc

Extended support

The vendor reports study, participant and site adoption across a stated country count.

Extended support means: Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.

Viedoc reports 8,000 studies, 1.6M participants and 30K sites in 75+ countries, and Everest Group rated it a Leader in 2024.

Source

Extended support

A self-service designer and database updates without downtime are both stated.

Extended support means: Study setup is described, and post-go-live changes explicitly avoid interrupting live study use.

Viedoc offers a drag-and-drop designer with reusable templates and states that database updates go live without downtime or vendor handoffs.

Source

Supported

Release-level Part 11 testing and ISO/SOC claims are stated; public document access is not established.

Supported means: Relevant trial compliance or security controls are stated, with their scope identified.

Viedoc is certified to ISO 27001:2022, has a SOC 2 Type 2 report and runs a 21 CFR Part 11 test suite for every release.

Source

Extended support

Native randomization, trial supply, medical coding and ePRO are all named.

Extended support means: Native randomization, trial supply management, medical coding, and either eCOA or ePRO are documented alongside EDC.

Viedoc lists native randomization, trial supply management, medical coding and ePRO; consent is offered as remote consent rather than a named eConsent module, and there is no CTMS.

Source

Supported

A web API is documented; the CDISC export format is not named.

Supported means: An API for clinical data exchange is stated.

Viedoc documents a web API (Swagger, OAuth 2.0) for data import and export and refers to CDISC-compliant formats, but names no ODM or SDTM export.

Source

Supported

Supported means: A pricing basis, model or contract terms are published beyond contact sales.

Viedoc publishes its pricing model (single-study or multi-study licenses, unlimited users, no setup fee for self-built studies) but no prices.

Source
  • Supported
  • Extended support
  • Not available
  • Unknown
What do the checks mean for this guide?

Every product uses the same definitions. Double checks indicate documented extra capabilities in that column; they do not indicate an overall winner. Unknown means the available sources do not establish support.

Track record in regulated multi-site trials
Supported: Published product or wider-platform adoption, or a named clinical-research deployment.
Extended support: Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
Study build and mid-study changes
Supported: Study setup or post-go-live study changes are described.
Extended support: Study setup is described, and post-go-live changes explicitly avoid interrupting live study use.
Compliance and security
Supported: Relevant trial compliance or security controls are stated, with their scope identified.
Extended support: Relevant trial controls and a publicly accessible ISO certificate or SOC audit report covering the product or vendor are documented.
Platform breadth
Supported: EDC connects to another named clinical-trial module.
Extended support: Native randomization, trial supply management, medical coding, and either eCOA or ePRO are documented alongside EDC.
APIs and data standards
Supported: An API for clinical data exchange is stated.
Extended support: An API plus data exchange in a named CDISC format are documented.
Published pricing and terms
Supported: A pricing basis, model or contract terms are published beyond contact sales.
Extended support: Production prices or a free production option are published, with amounts and conditions stated.
Read the detailed feature comparison

Select a feature label for its details and source. Scroll sideways for all features.

Feature statements for each product, with public sources. Products appear in editorial order.
SoftwareTrack record in regulated multi-site trialsStudy build and mid-study changesCompliance and securityPlatform breadthAPIs and data standardsPublished pricing and terms
Medidata Rave EDC
38K+ studies + 1.8M+ users (vendor claim) — details and source

Medidata's Rave EDC page reports 38K+ studies, 1.8M+ users and 25+ years in use.

Source
Drag-and-drop; no-downtime changes stated — details and source

Medidata states that Rave deploys mid-study changes with no downtime and that studies are built with drag-and-drop design and libraries of pre-validated eCRFs.

Source
ISO/SOC listed; Part 11 statements for customers — details and source

Medidata lists ISO 27001:2022, ISO 27017, ISO 27018, ISO 27701 and a SOC 2+ Type II audit, and provides 21 CFR Part 11 position statements to customers.

Source
Native RTSM, Coder+, eCOA + eConsent — details and source

Rave EDC connects to Medidata's own RTSM, Coder+, eCOA, eConsent, Imaging and Clinical Data Studio.

Source
REST API + CDISC ODM + EHR connector — details and source

Rave Web Services is a REST API that exchanges data in CDISC ODM, and Medidata lists Health Record Connect for EHR data on its EDC page.

Source
Rave Lite flexible model; prices unpublished — details and source

Medidata publishes no prices; its EDC page only says Rave Lite has a flexible pricing model.

Source
Castor
31,900+ studies reported; Phase III not evidenced — details and source

Castor reports more than 31,900 studies with 9.5 million participants in 171 countries, but its pages give no evidence of global Phase III programs.

Source
Low-code self-build + audited mid-study edits — details and source

Castor offers self-service build with a low-code eCRF builder and reusable templates, and says forms can be edited mid-study with audit trails and separate test environments, without a no-downtime claim.

Source
Part 11, Annex 11 + ISO 27001 listed — details and source

Castor lists FDA 21 CFR Part 11, EU Annex 11 and ISO 27001 among its compliance standards.

Source
eConsent/ePRO/eSource; no native supply or CTMS — details and source

Castor's EDC page lists eConsent, ePRO/eCOA and eSource; it lists no native trial supply management, coding or CTMS.

Source
API + FHIR/EHR; CDISC export not specified — details and source

Castor offers an open API, says it aligns with HL7 FHIR and integrates with EHRs, but makes no specific CDISC export claim.

Source
Fixed-scope quotes; prices not published — details and source

No prices published; Castor's pricing page describes an itemized, fixed-scope proposal with change-control terms, sent within five business days.

Source
Medrio
30+ countries; study count not published — details and source

Medrio cites 20+ years of use, sites in 30+ countries and trials from early feasibility to pivotal studies, but its current pages show no study count.

Source
No-code; updates without migration stated — details and source

Medrio describes a no-code drag-and-drop builder with a template library and says updates deploy without data migration, vendor delays or extended downtime.

Source
SOC 2 Type 2 (2022); Part 11 support stated — details and source

Medrio completed a SOC 2 Type 2 examination in 2022, and its EDC page states support for 21 CFR Part 11, ICH E6(R2), HIPAA and GDPR.

Source
EDC/eCOA/eConsent/RTSM/CTMS/eTMF; coding unlisted — details and source

Medrio lists EDC, ePRO/eCOA, eConsent, RTSM (randomization and supply), CTMS and eTMF; coding is not listed.

Source
Import/export APIs; CDISC format not named — details and source

Medrio mentions import and export APIs and industry-standard exports but publishes no API documentation or named CDISC format.

Source
Subscription; prices not published — details and source

No prices published; Medrio describes its pricing as subscription-based.

Source
OpenClinica
15,000+ studies + 3M+ patients (vendor claim) — details and source

OpenClinica says its technology has powered over 15,000 studies and more than three million patients.

Source
Self/free managed build; amendments not documented — details and source

OpenClinica offers drag-and-drop self-build with CDASH templates or a free expert-managed build, but does not publicly document how amendments deploy.

Source
Part 11/HIPAA + ISO 27001/SOC 2 stated — details and source

OpenClinica states 21 CFR Part 11, ICH GCP, HIPAA and GDPR compliance and lists SOC 2 Type II and ISO 27001 certification.

Source
eConsent/eCOA/randomization; no native supply/coding — details and source

OpenClinica lists EDC with eConsent, eCOA, randomization, EHR-to-EDC and reporting; it has no native trial supply management or coding.

Source
REST API + CDISC ODM 1.3.2 + EHR-to-EDC — details and source

OpenClinica documents a REST API that imports and retrieves clinical data as CDISC ODM 1.3.2 XML or JSON, and it offers EHR-to-EDC.

Source
Launch $750/month; Core $3,000/study/month, 12 months — details and source

OpenClinica publishes prices: EDC-only Launch at $750 a month with a 30-day free trial, and Core at $3,000 a month per study on a 12-month contract.

Source
Oracle
Clinical One study/customer count not published — details and source

Everest Group rated Oracle a Leader in its 2024 EDC assessment, but we found no published Clinical One study or customer count.

Source
Live versioning; downtime claim not verified — details and source

Oracle documents versioned changes to live studies, including Advanced Study Versioning and several versions in production, but we could not load an Oracle page that states changes run without downtime.

Source
Audit trails documented; Part 11 not found — details and source

Oracle documents electronic signatures and audit-trail datasets for Clinical One, and its cloud compliance page lists ISO 27001 attestations by line of business, but we found no public Part 11 statement specific to Clinical One.

Source
Native RTSM/coding; eCOA/eConsent via partners — details and source

Clinical One combines data collection with randomization and trial supply management, Central Coding and Analytics; eCOA and eConsent come through partner integrations.

Source
About 18 REST APIs + ODM integrations — details and source

Oracle documents about 18 REST APIs for Clinical One, ODM-format integrations, CDISC LAB data intake and a catalog of named integrations.

Source
Prices and model not published — details and source

Oracle publishes no Clinical One prices or pricing model.

Source
WeGuide
Named clinical research deployments — details and source

Public research examples include BRACE and INHERIT. These document research use of the participant platform, rather than counts of full enterprise EDC deployments or regulatory submissions.

Source
Configurable study forms, logic and validation — details and source

Study teams configure forms, question types, conditional logic, input validation and testing. This supports focused trial data collection; uninterrupted enterprise-EDC database amendments are not established by the public material.

Source
Trial/privacy controls and ISO certification stated — details and source

WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report.

Source
Consent, questionnaires and optional EDC connections — details and source

Study programs combine participant forms, ePRO, consent and follow-up. REDCap and other EDC connections can be configured where additional clinical-data workflows require them. A native enterprise EDC, medical-coding and supply-management suite is not claimed.

Source
REST/FHIR APIs; CDISC export not documented — details and source

REST and FHIR integration methods are documented. A named CDISC-format export is not established in the reviewed public material.

Source
Per-study quote; amounts not published — details and source

WeGuide publishes a per-study quote basis. Contact the team for a study-specific quote; numerical prices are not published.

Source
REDCap
8,526 institutions; nonprofit/academic focus — details and source

The REDCap Consortium lists 8,526 institutions in 167 countries and 2.9M projects, but REDCap is licensed to non-profits and its use is concentrated in academic research.

Source
Self-build + approval of live-project changes — details and source

Teams build REDCap projects themselves in the online designer, and changes to live projects are drafted and approved in production mode.

Source
Part 11 depends on institution; varies by host — details and source

Vanderbilt says REDCap can be installed for 21 CFR Part 11 compliance, but this depends on each institution's setup; Penn Medicine, for example, states its REDCap is not Part 11-compliant.

Source
Randomization + eConsent; no supply/coding/CTMS — details and source

REDCap includes randomization, e-Consent and participant surveys, but no trial supply management, coding or CTMS.

Source
API + CDISC ODM export + FHIR pulls — details and source

REDCap has an API and exports CDISC ODM (per Yale's REDCap guide), and the REDCap software page documents EHR data pulls over FHIR.

Source
Free to nonprofit consortium members only — details and source

REDCap is free for non-profit members of the REDCap Consortium; for-profit organizations are not eligible.

Source
Veeva
100+ EDC customers (vendor claim); no study count — details and source

Veeva reports 100+ EDC customers and says eight of the top 20 biopharmas have switched to Veeva EDC, but publishes no study count.

Source
Amendments without migration; brief casebook lockout — details and source

Veeva's white paper states that amendments add new elements without bringing the system down or migrating data, with only a brief casebook lockout while a change deploys.

Source
ISO/SOC listed; Part 11 eSignature stated — details and source

Veeva's trust page lists ISO 27001, ISO 27017, ISO 27018 and a SOC 2 Type II report, and its EDC help docs state that Veeva EDC eSignature meets 21 CFR Part 11.

Source
EDC/eCOA/RTSM/DQS + CTMS/eConsent products — details and source

Veeva's clinical data suite lists EDC, eCOA, RTSM (randomization and supply) and DQS data management, and Veeva also sells CTMS and eConsent.

Source
CDMS API; ODM casebook export is legacy — details and source

Veeva documents a versioned CDMS API for study data, definitions and coding requests with a data model similar to CDISC ODM, but its ODM casebook export is a legacy feature.

Source
Prices and model not published — details and source

Veeva publishes no EDC prices or pricing model.

Source
Viedoc
8,000 studies + 75+ countries (vendor claim) — details and source

Viedoc reports 8,000 studies, 1.6M participants and 30K sites in 75+ countries, and Everest Group rated it a Leader in 2024.

Source
Self-build; no-downtime updates stated — details and source

Viedoc offers a drag-and-drop designer with reusable templates and states that database updates go live without downtime or vendor handoffs.

Source
ISO 27001/SOC 2 + Part 11 release testing stated — details and source

Viedoc is certified to ISO 27001:2022, has a SOC 2 Type 2 report and runs a 21 CFR Part 11 test suite for every release.

Source
Native supply/coding/ePRO; remote consent, no CTMS — details and source

Viedoc lists native randomization, trial supply management, medical coding and ePRO; consent is offered as remote consent rather than a named eConsent module, and there is no CTMS.

Source
Web API; ODM/SDTM export not named — details and source

Viedoc documents a web API (Swagger, OAuth 2.0) for data import and export and refers to CDISC-compliant formats, but names no ODM or SDTM export.

Source
Study licenses, unlimited users; prices unpublished — details and source

Viedoc publishes its pricing model (single-study or multi-study licenses, unlimited users, no setup fee for self-built studies) but no prices.

Source

The short list

Products in editorial order
  • Medidata Rave EDCStudy fit: large sponsors and CROs running global Phase II and III programs that want EDC, RTSM, coding and eCOA from one vendor.
  • CastorStudy fit: academic groups, biotechs and device teams running investigator-initiated or mid-size studies who want to build studies themselves.
  • MedrioStudy fit: small and mid-size sponsors and CROs that want a no-code EDC with RTSM, eCOA and eConsent from one vendor.
  • OpenClinicaStudy fit: academic groups, CROs and small sponsors that want published per-study prices and standards-based data exchange.
  • Oracle Clinical OneStudy fit: large sponsors and CROs that want data collection and randomization and supply management on one Oracle platform.
  • WeGuideStudy fit: clinical trials and research studies that need participant-data collection and ongoing engagement, with consent, forms, ePRO, follow-up and connections to existing systems
  • REDCapStudy fit: academic and non-profit teams running investigator-initiated studies, as a free baseline.
  • Veeva EDCStudy fit: sponsors and CROs already on Veeva's clinical platform who want EDC, RTSM, eCOA and CTMS from the same vendor.
  • ViedocStudy fit: sponsors and CROs of any size running multi-country trials who want a per-study license with unlimited users.

Compare at a glance

SoftwareAnalyst ratingSecurity certificationsAPI and integrationsPricing model
Medidata Rave EDC

Leader, Everest Group Life Sciences EDC PEAK Matrix 2024

Source

ISO 27001:2022, ISO 27017:2015, ISO 27018:2019, ISO 27701:2019, SOC 2+ Type II

Source

Rave Web Services REST API exchanging CDISC ODM

Source

No prices published; the Patient Cloud service descriptions publish contract terms (devices on a rental basis, caps on fee adjustments, early-termination fees)

Source
Castor

Major Contender, Everest Group Life Sciences EDC PEAK Matrix 2024

Source

ISO/IEC 27001:2022 (certificate published); ISO 9001 and NEN 7510 stated in its help center

Source

Open API; HL7 FHIR alignment; EHR, lab and wearable integrations

Source

Per-study flat-rate license, no per-subject fees, quote within five business days

Source
Medrio

Major Contender, Everest Group Life Sciences EDC PEAK Matrix 2024

Source

ISO 27001, SOC 2 and ISO 9001

Source

Medrio API Connect (REST)

Source

Transparent, subscription-based pricing (stated); no prices published

Source
OpenClinica

Major Contender, Everest Group Life Sciences EDC PEAK Matrix 2024

Source

SOC 2 Type II certified; ISO 27001 certified

Source

REST clinicaldata API: import as CDISC ODM 1.3.2 XML, retrieve as ODM XML or JSON, bearer-token auth

Source

Launch $750/month (EDC only, max 150 participants and 3 sites, no API); Core $3,000/month per study; Advanced $3,750/month per study (12-month contracts); services $275-$350/hour

Source
Oracle Clinical One

Leader, Everest Group Life Sciences EDC PEAK Matrix 2024

Source

Oracle cloud compliance page lists ISO 27001 and other attestations per line of business; Clinical One scope not stated

Source

About 18 documented REST APIs; ODM-format integrations; CDISC LAB intake; published integration catalog

Source

Not published

Source
WeGuide

Needs facts

ISO 27001:2022 (stated; certificate not published); no SOC 2 claim found

Source

Named REDCap, Castor and Medidata Rave connections. Integration methods, field mapping and study workflows are configured for the project; REST and FHIR are listed as possible methods.

Source

Quoted per study, with hosting, support and modules included. Email hello@weguide.health for a study-specific quote; price amounts are not published.

Source
REDCap

Needs facts

None at vendor level; set by each hosting institution

Source

REDCap API; FHIR-based EHR data pull

Source

Free license, code and support for nonprofit consortium members, who self-host; for-profit use through REDCap Cloud or VUMC hosting for a fee

Source
Veeva EDC

Leader, Everest Group Life Sciences EDC PEAK Matrix 2024

Source

ISO 27001, ISO 27017, ISO 27018 controls audited yearly; SOC 2 Type II report; ISO 9001

Source

Versioned Vault CDMS API (data, definitions, coding requests, jobs); data model similar to CDISC ODM; ODM casebook export is legacy

Source

Not published

Source
Viedoc

Leader, Everest Group Life Sciences EDC PEAK Matrix 2024

Source

ISO 27001:2022 (company-wide); SOC 2 Type 2 report on request; HIPAA security compliance assessment published

Source

Web API documented in Swagger, OAuth 2.0 client credentials, scoped per study; export formats XLSX, CSV, XPT, RDS

Source

Model published, prices not published; special pricing for nonprofits and academic institutions; no free trial, training server on request

Source

Product details

Medidata Rave EDC

Study fit: large sponsors and CROs running global Phase II and III programs that want EDC, RTSM, coding and eCOA from one vendor.

Rave EDC reports 38K+ studies and documents native clinical data modules. Medidata publishes no prices.

Track record in regulated multi-site trials

Medidata's Rave EDC page reports 38K+ studies, 1.8M+ users and 25+ years in use.

Source
Study build and mid-study changes

Medidata states that Rave deploys mid-study changes with no downtime and that studies are built with drag-and-drop design and libraries of pre-validated eCRFs.

Source
Compliance and security

Medidata lists ISO 27001:2022, ISO 27017, ISO 27018, ISO 27701 and a SOC 2+ Type II audit, and provides 21 CFR Part 11 position statements to customers.

Source
Platform breadth

Rave EDC connects to Medidata's own RTSM, Coder+, eCOA, eConsent, Imaging and Clinical Data Studio.

Source
APIs and data standards

Rave Web Services is a REST API that exchanges data in CDISC ODM, and Medidata lists Health Record Connect for EHR data on its EDC page.

Source
Published pricing and terms

Medidata publishes no prices; its EDC page only says Rave Lite has a flexible pricing model.

Source
Pricing model
No prices published; the Patient Cloud service descriptions publish contract terms (devices on a rental basis, caps on fee adjustments, early-termination fees)Source
Security certifications
ISO 27001:2022, ISO 27017:2015, ISO 27018:2019, ISO 27701:2019, SOC 2+ Type IISource
Headquarters
New York, NY (350 Hudson Street, per ISO certificate)Source

Less suitable for teams that need published prices or a self-serve contract for a single small study.

View the Medidata profile Visit website

Castor

Study fit: academic groups, biotechs and device teams running investigator-initiated or mid-size studies who want to build studies themselves.

Castor has a large published study footprint and strong certifications, and teams can build studies without vendor help. It offers fewer native modules than the enterprise suites, and Everest Group placed it as a Major Contender rather than a Leader in 2024.

Track record in regulated multi-site trials

Castor reports more than 31,900 studies with 9.5 million participants in 171 countries, but its pages give no evidence of global Phase III programs.

Source
Study build and mid-study changes

Castor offers self-service build with a low-code eCRF builder and reusable templates, and says forms can be edited mid-study with audit trails and separate test environments, without a no-downtime claim.

Source
Compliance and security

Castor lists FDA 21 CFR Part 11, EU Annex 11 and ISO 27001 among its compliance standards.

Source
Platform breadth

Castor's EDC page lists eConsent, ePRO/eCOA and eSource; it lists no native trial supply management, coding or CTMS.

Source
APIs and data standards

Castor offers an open API, says it aligns with HL7 FHIR and integrates with EHRs, but makes no specific CDISC export claim.

Source
Published pricing and terms

No prices published; Castor's pricing page describes an itemized, fixed-scope proposal with change-control terms, sent within five business days.

Source
Pricing model
Per-study flat-rate license, no per-subject fees, quote within five business daysSource
Compliance claims
Listed: FDA 21 CFR Part 11, EU Annex 11, ICH E6(R3) GCP, EU GDPR, EU MDR 2017/745 (PMCF)Source
Security certifications
ISO/IEC 27001:2022 (certificate published); ISO 9001 and NEN 7510 stated in its help centerSource
API and integrations
Open API; HL7 FHIR alignment; EHR, lab and wearable integrationsSource

Less suitable for global pivotal programs that need the largest instrument libraries and published regulatory track records

View the Castor profile Visit website

Medrio

Study fit: small and mid-size sponsors and CROs that want a no-code EDC with RTSM, eCOA and eConsent from one vendor.

Medrio documents study-build tools and connected clinical modules. It publishes less than the others about its scale, its APIs and its pricing.

Track record in regulated multi-site trials

Medrio cites 20+ years of use, sites in 30+ countries and trials from early feasibility to pivotal studies, but its current pages show no study count.

Source
Study build and mid-study changes

Medrio describes a no-code drag-and-drop builder with a template library and says updates deploy without data migration, vendor delays or extended downtime.

Source
Compliance and security

Medrio completed a SOC 2 Type 2 examination in 2022, and its EDC page states support for 21 CFR Part 11, ICH E6(R2), HIPAA and GDPR.

Source
Platform breadth

Medrio lists EDC, ePRO/eCOA, eConsent, RTSM (randomization and supply), CTMS and eTMF; coding is not listed.

Source
APIs and data standards

Medrio mentions import and export APIs and industry-standard exports but publishes no API documentation or named CDISC format.

Source
Published pricing and terms

No prices published; Medrio describes its pricing as subscription-based.

Source
Pricing model
Transparent, subscription-based pricing (stated); no prices publishedSource
Compliance claims
States support for FDA 21 CFR Part 11, ICH E6(R2), HIPAA and GDPRSource
Security certifications
ISO 27001, SOC 2 and ISO 9001Source
API and integrations
Medrio API Connect (REST)Source

Less suitable for teams that need documented open APIs or native medical coding.

View the Medrio profile Visit website

OpenClinica

Study fit: academic groups, CROs and small sponsors that want published per-study prices and standards-based data exchange.

OpenClinica is the only commercial EDC here with public list prices, and it documents an ODM-based REST API. It has fewer native modules than the enterprise suites, and Everest Group rated it a Major Contender, not a Leader, in 2024.

Track record in regulated multi-site trials

OpenClinica says its technology has powered over 15,000 studies and more than three million patients.

Source
Study build and mid-study changes

OpenClinica offers drag-and-drop self-build with CDASH templates or a free expert-managed build, but does not publicly document how amendments deploy.

Source
Compliance and security

OpenClinica states 21 CFR Part 11, ICH GCP, HIPAA and GDPR compliance and lists SOC 2 Type II and ISO 27001 certification.

Source
Platform breadth

OpenClinica lists EDC with eConsent, eCOA, randomization, EHR-to-EDC and reporting; it has no native trial supply management or coding.

Source
APIs and data standards

OpenClinica documents a REST API that imports and retrieves clinical data as CDISC ODM 1.3.2 XML or JSON, and it offers EHR-to-EDC.

Source
Published pricing and terms

OpenClinica publishes prices: EDC-only Launch at $750 a month with a 30-day free trial, and Core at $3,000 a month per study on a 12-month contract.

Source
Pricing model
Launch $750/month (EDC only, max 150 participants and 3 sites, no API); Core $3,000/month per study; Advanced $3,750/month per study (12-month contracts); services $275-$350/hourSource
Compliance claims
States 21 CFR Part 11, ICH GCP E6(R2), HIPAA and GDPR complianceSource
Security certifications
SOC 2 Type II certified; ISO 27001 certifiedSource
API and integrations
REST clinicaldata API: import as CDISC ODM 1.3.2 XML, retrieve as ODM XML or JSON, bearer-token authSource

Less suitable for sponsors that need native trial supply management and medical coding in the EDC platform.

View the OpenClinica profile Visit website

Oracle Clinical One

Study fit: large sponsors and CROs that want data collection and randomization and supply management on one Oracle platform.

Clinical One unifies EDC and RTSM and has a well-documented API. Public information gaps include a study count, a Part 11 statement specific to Clinical One and prices; we could not find these in the sources checked.

Track record in regulated multi-site trials

Everest Group rated Oracle a Leader in its 2024 EDC assessment, but we found no published Clinical One study or customer count.

Source
Study build and mid-study changes

Oracle documents versioned changes to live studies, including Advanced Study Versioning and several versions in production, but we could not load an Oracle page that states changes run without downtime.

Source
Compliance and security

Oracle documents electronic signatures and audit-trail datasets for Clinical One, and its cloud compliance page lists ISO 27001 attestations by line of business, but we found no public Part 11 statement specific to Clinical One.

Source
Platform breadth

Clinical One combines data collection with randomization and trial supply management, Central Coding and Analytics; eCOA and eConsent come through partner integrations.

Source
APIs and data standards

Oracle documents about 18 REST APIs for Clinical One, ODM-format integrations, CDISC LAB data intake and a catalog of named integrations.

Source
Published pricing and terms

Oracle publishes no Clinical One prices or pricing model.

Source
Pricing model
Not publishedSource
Security certifications
Oracle cloud compliance page lists ISO 27001 and other attestations per line of business; Clinical One scope not statedSource
Headquarters
Austin, Texas (Oracle Corporation)Source

Less suitable for teams that need native eCOA or eConsent from the EDC vendor, or published prices.

View the Oracle profile Visit website

WeGuide

Study fit: clinical trials and research studies that need participant-data collection and ongoing engagement, with consent, forms, ePRO, follow-up and connections to existing systems

Study fit source

WeGuide brings participant-data collection and ongoing engagement into one study program for clinical trials and research studies. Teams can run screening, consent, forms, ePRO, reminders and follow-up in a branded participant app. The Integration Engine connects existing research systems when required. If the protocol needs intensive site-entered clinical data, complex queries, medical coding or advanced database management, use an appropriate EDC alongside the participant workflow. Suitability depends on those requirements, rather than study size or phase alone.

Track record in regulated multi-site trials

Public research examples include BRACE and INHERIT. These document research use of the participant platform, rather than counts of full enterprise EDC deployments or regulatory submissions.

Source
Study build and mid-study changes

Study teams configure forms, question types, conditional logic, input validation and testing. This supports focused trial data collection; uninterrupted enterprise-EDC database amendments are not established by the public material.

Source
Compliance and security

WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report.

Source
Platform breadth

Study programs combine participant forms, ePRO, consent and follow-up. REDCap and other EDC connections can be configured where additional clinical-data workflows require them. A native enterprise EDC, medical-coding and supply-management suite is not claimed.

Source
APIs and data standards

REST and FHIR integration methods are documented. A named CDISC-format export is not established in the reviewed public material.

Source
Published pricing and terms

WeGuide publishes a per-study quote basis. Contact the team for a study-specific quote; numerical prices are not published.

Source
Pricing model
Quoted per study, with hosting, support and modules included. Email hello@weguide.health for a study-specific quote; price amounts are not published.Source
Compliance claims
Supports 21 CFR Part 11 requirements (stated); EU Annex 11 not statedSource
Compliance claims
WeGuide states 21 CFR Part 11 and HIPAA support; confirm the study-specific validation scope and BAA requirements.Source
Security certifications
ISO 27001:2022 (stated; certificate not published); no SOC 2 claim foundSource

Less suitable for protocols requiring extensive in-visit eCRFs, complex data queries, medical coding, source-data verification or an enterprise database-lock workflow.

View the WeGuide profile Visit website

REDCap

Study fit: academic and non-profit teams running investigator-initiated studies, as a free baseline.

REDCap is the free academic baseline, with open data standards and very wide adoption. It comes without vendor support, its Part 11 status depends on each institution, and sponsors and CROs cannot license it.

Track record in regulated multi-site trials

The REDCap Consortium lists 8,526 institutions in 167 countries and 2.9M projects, but REDCap is licensed to non-profits and its use is concentrated in academic research.

Source
Study build and mid-study changes

Teams build REDCap projects themselves in the online designer, and changes to live projects are drafted and approved in production mode.

Source
Compliance and security

Vanderbilt says REDCap can be installed for 21 CFR Part 11 compliance, but this depends on each institution's setup; Penn Medicine, for example, states its REDCap is not Part 11-compliant.

Source
Platform breadth

REDCap includes randomization, e-Consent and participant surveys, but no trial supply management, coding or CTMS.

Source
APIs and data standards

REDCap has an API and exports CDISC ODM (per Yale's REDCap guide), and the REDCap software page documents EHR data pulls over FHIR.

Source
Published pricing and terms

REDCap is free for non-profit members of the REDCap Consortium; for-profit organizations are not eligible.

Source
Pricing model
Free license, code and support for nonprofit consortium members, who self-host; for-profit use through REDCap Cloud or VUMC hosting for a feeSource
Compliance claims
Can be installed for compliance with HIPAA, 21 CFR Part 11 and FISMA; status depends on each institution's installationSource
Security certifications
None at vendor level; set by each hosting institutionSource
API and integrations
REDCap API; FHIR-based EHR data pullSource

Less suitable for industry sponsors and CROs (not eligible to license it), and trials that need a vendor-validated Part 11 system with vendor support.

View the REDCap profile Visit website

Veeva EDC

Study fit: sponsors and CROs already on Veeva's clinical platform who want EDC, RTSM, eCOA and CTMS from the same vendor.

Veeva EDC documents mid-study changes and connected clinical applications, and Veeva says eight of the top 20 biopharmas have switched to it. Veeva publishes no study count and no prices.

Track record in regulated multi-site trials

Veeva reports 100+ EDC customers and says eight of the top 20 biopharmas have switched to Veeva EDC, but publishes no study count.

Source
Study build and mid-study changes

Veeva's white paper states that amendments add new elements without bringing the system down or migrating data, with only a brief casebook lockout while a change deploys.

Source
Compliance and security

Veeva's trust page lists ISO 27001, ISO 27017, ISO 27018 and a SOC 2 Type II report, and its EDC help docs state that Veeva EDC eSignature meets 21 CFR Part 11.

Source
Platform breadth

Veeva's clinical data suite lists EDC, eCOA, RTSM (randomization and supply) and DQS data management, and Veeva also sells CTMS and eConsent.

Source
APIs and data standards

Veeva documents a versioned CDMS API for study data, definitions and coding requests with a data model similar to CDISC ODM, but its ODM casebook export is a legacy feature.

Source
Published pricing and terms

Veeva publishes no EDC prices or pricing model.

Source
Pricing model
Not publishedSource
Security certifications
ISO 27001, ISO 27017, ISO 27018 controls audited yearly; SOC 2 Type II report; ISO 9001Source
Headquarters
4280 Hacienda Drive, Pleasanton, CA 94588Source

Less suitable for teams that need published prices, or a stand-alone EDC with a short single-study contract.

View the Veeva profile Visit website

Viedoc

Study fit: sponsors and CROs of any size running multi-country trials who want a per-study license with unlimited users.

Viedoc combines an Everest Group Leader rating with no-downtime study changes, strong certifications and a published pricing model. It has no native CTMS and no named eConsent module.

Track record in regulated multi-site trials

Viedoc reports 8,000 studies, 1.6M participants and 30K sites in 75+ countries, and Everest Group rated it a Leader in 2024.

Source
Study build and mid-study changes

Viedoc offers a drag-and-drop designer with reusable templates and states that database updates go live without downtime or vendor handoffs.

Source
Compliance and security

Viedoc is certified to ISO 27001:2022, has a SOC 2 Type 2 report and runs a 21 CFR Part 11 test suite for every release.

Source
Platform breadth

Viedoc lists native randomization, trial supply management, medical coding and ePRO; consent is offered as remote consent rather than a named eConsent module, and there is no CTMS.

Source
APIs and data standards

Viedoc documents a web API (Swagger, OAuth 2.0) for data import and export and refers to CDISC-compliant formats, but names no ODM or SDTM export.

Source
Published pricing and terms

Viedoc publishes its pricing model (single-study or multi-study licenses, unlimited users, no setup fee for self-built studies) but no prices.

Source
Pricing model
Model published, prices not published; special pricing for nonprofits and academic institutions; no free trial, training server on requestSource
Compliance claims
21 CFR Part 11 regulatory test suite run in Performance Qualification for every release; validation packet per releaseSource
Security certifications
ISO 27001:2022 (company-wide); SOC 2 Type 2 report on request; HIPAA security compliance assessment publishedSource
API and integrations
Web API documented in Swagger, OAuth 2.0 client credentials, scoped per study; export formats XLSX, CSV, XPT, RDSSource

Less suitable for teams that want CTMS or a dedicated eConsent module from the same vendor.

View the Viedoc profile Visit website

How we compare this software

This guide compares 9 products across the same feature topics. Each statement describes what the available public sources document, including limitations and study requirements.

Scope: Dedicated EDC systems and participant-centered clinical-trial data collection are compared by their documented capabilities. Whether a participant-centered platform also needs a dedicated EDC depends on in-visit data entry, clinical queries, coding, verification and database-management requirements, rather than study size or trial phase alone.

  • Track record in regulated multi-site trials
  • Study build and mid-study changes
  • Compliance and security
  • Platform breadth
  • APIs and data standards
  • Published pricing and terms

A vendor’s published claim is not independent confirmation that a product will meet your study’s needs. Check deployment, validation, integrations and commercial terms with the vendor.

Outside this comparison: Zelta (Merative), which Everest Group also rated a Leader in 2024, was not in our candidate set. REDCap Cloud is a separate commercial product from consortium REDCap and is not included here.

Read the comparison method

Questions about EDC software

What is an EDC system?

An electronic data capture (EDC) system replaces paper case report forms in a clinical trial. Sites enter data into electronic forms, the system checks entries, raises queries and keeps an audit trail, and the sponsor uses the cleaned data for analysis and regulatory submissions.

Which EDC systems suit global Phase III trials?

Medidata Rave EDC has the largest published footprint we found (38K+ studies). Everest Group's 2024 EDC assessment rated Medidata, Oracle, Veeva, Viedoc and Zelta (Merative) as Leaders; Medidata, Oracle, Veeva and Viedoc are compared on this page. Assess their documented capabilities against your Phase III requirements.

How much does EDC software cost?

Most vendors publish no prices. OpenClinica is the exception: its EDC-only Launch plan is $750 a month and its Core plan is $3,000 a month per study on a 12-month contract. Viedoc publishes its pricing model (per-study license, unlimited users) without prices, and REDCap is free for non-profit consortium members.

Is REDCap 21 CFR Part 11 compliant?

It can be, but not by default. Vanderbilt says REDCap can be installed for Part 11 compliance; each institution runs and validates its own installation, and some, such as Penn Medicine, state that their instance is not Part 11-compliant.

Can I change an EDC study after go-live?

Yes. Medidata, Veeva, Medrio and Viedoc state that mid-study changes deploy without system downtime, and Oracle documents versioning of live studies. Ask each vendor how an amendment affects data already entered.